Samuel Nwite
AUTHOR: Samuel Nwite
U.S. Stocks Rebound Modestly as Chip Sector Leads Recovery and Middle East Tensions Ease...
U.S. stocks ended mostly higher on Monday, with the Nasdaq and semiconductor shares leading a partial recovery from Friday’s sharp selloff, as investors hunted...
GSK to Acquire U.S. Biotech Firm Nuvalent for $10.6bn in Largest Pharma Deal in...
GSK has agreed to acquire U.S. biotech firm Nuvalent in a $10.6 billion all-cash transaction, marking its biggest acquisition in more than ten years...
AI Trade Roars Back Across Asia as Chip Stocks Rally, but IPO Wave Raises...
Artificial intelligence-linked technology stocks staged a strong rebound across Asia on Tuesday, mirroring gains on Wall Street as investors returned to semiconductor and AI...
Perplexity Confirms 2028 IPO as AI Listing Wave Tests Investor Appetite for Trillion-Dollar Valuations
Perplexity is pressing ahead with plans to go public in 2028, positioning itself as the next major artificial intelligence company likely to tap public...
DOJ Denies Allegations Of Retaliation Against Anthropic As Lawsuit Tests Limits Of Government Power...
The Trump administration has acknowledged that U.S. agencies moved to restrict the use of Anthropic's artificial intelligence products after the company resisted Pentagon demands...